COVID-19 Vaccines: Global Regulators Define Preclinical Data Requirements

Address Thorny Issue Of Studying Vaccine-Induced Disease Enhancement

 
• By Vibha Sharma
  
Balance
Balance Is Needed Between Robust Data And Speeding Vaccine Development • Source: Shutterstock

More from Clinical Trials

More from R&D